Journal
ADVANCES IN MEDICAL SCIENCES
Volume 64, Issue 2, Pages 388-394Publisher
MEDICAL UNIV BIALYSTOK
DOI: 10.1016/j.advms.2019.05.002
Keywords
Colorectal cancer; Metastasis; P2X7 receptor; Prognosis; Survival period
Categories
Funding
- National Natural Science Foundation of China [81471466]
Ask authors/readers for more resources
Purpose: Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the world. P2X7 receptor (P2X7R), encoded by the P2rx7 gene, is a trimeric ion channel activated by extracellular Adenosine triphosphate and is widely expressed in various types of tissues and tumors to regulate inflammation, cell proliferation, or death. The discovery of new biomarkers and understanding the role of P2X7R in CRC are therefore critical to improving the prognosis and treatment of CRC. Materials and methods: P2X7R expression was analyzed in CRC tumor samples and normal colorectal tissues from 97 patients and various colon cancer cell lines. The correlation of tumor antigens, survival periods, and P2X7R expression were documented. Results: P2X7R(High )and P2X7R(Low )populations were observed in CRC patients. P2X7R(High ) patients had relatively shorter survival periods, higher levels of serum carcinoembryonic antigen, and greater numbers of advanced tumors. In addition, P2X7R expression had a significant up-regulation in metastatic CRC and metastatic CRC cell lines, which indicates that P2X7R expression is positively associated with metastasis. Conclusions: P2X7R expression might be a potential biomarker for prognosis and metastasis of CRC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available